Live tape
Top 8, mentions 7d6,223META1,812 mentions▲ +0.06GOOGL1,253 mentions▲ +0.02NVDA720 mentions▲ +0.09MSFT539 mentions▲ +0.06MUSE508 mentions▲ +0.06TSLA481 mentions▲ +0.05SPY476 mentions▲ +0.04QQQ434 mentions▲ +0.07

Equity · Healthcare

BLTE

Belite Bio, Inc · NasdaqCM

$167 −1.53% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 25, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$200 $140 1 Jul 25 Sep

The line runs $142 on 1 July through $167 on 25 September, on a scale from $140 to $200. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of BLTE over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $142 on 1 July 2026 through $167 on 25 September 2026.

52-week range $69.64 – $194
Avg volume 10.4K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · as of Sep 25, 2026

Filings 3 sets

BLTE reported financials

SEC EDGAR XBRL

BLTE reported net income of −$77.6M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$77.6M 31 Dec 2025 fiscal year
Diluted EPS −$2.31 31 Dec 2025 fiscal year
Total assets $780.6M 31 Dec 2025 at period end
Total equity $770.5M 31 Dec 2025 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025

BLTE institutional holders

SEC Form 13F

7 of the 45 institutional funds we track reported a BLTE position for the quarter ended 30 Jun 2026 — a combined $204.5M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Held (±25%) −13.2% shares 494,564 $76.2M
Maverick Capital New position 396,311 $61.0M
Citadel Advisors Added +9,171.3% shares 186,168 $28.7M
Duquesne Family Office Held (±25%) 106,100 $16.3M
Renaissance Technologies Held (±25%) +7.2% shares 55,763 $8.6M
Point72 Asset Management New position 51,186 $7.9M
Two Sigma Investments New position 38,100 $5.9M
Tudor Investment Corp Exited

Source: SEC EDGAR 13F filings

BLTE fails-to-deliver

SEC CNS data

On 28 Aug 2026, 3,228 shares of BLTE failed to deliver (about $507K) — the latest of 4 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
28 Aug 2026 3,228 $507K 0.008%
27 Aug 2026 5,572 $873K 0.014%
26 Aug 2026 2,057 $333K 0.005%
25 Aug 2026 2,019 $321K 0.005%
21 Aug 2026 1,621 $263K 0.004%
20 Aug 2026 2,230 $376K 0.006%
19 Aug 2026 1,628 $265K 0.004%
18 Aug 2026 1,353 $221K 0.003%

Source: SEC fails-to-deliver (CNS) data